This page shows the latest Sage news and features for those working in and with pharma, biotech and healthcare.
The WHO’s Strategic Advisory Group of Experts (Sage) backed use of the jab in adults, including those aged over 65, despite some EU countries having ruled out giving the vaccine ... The Sage panel also recommended that the vaccine should be
The formal EUL follows a recommendation from the WHO’s Strategic Advisory Group of Experts (Sage) last week that backed the use of the vaccine in adults, including those aged over ... This dosing interval was recommend by the WHO’s Sage, which also
WHO's Sage panel also recommends a two-dose regimen given eight to 12 weeks apart. ... The Sage panel has also recommended that the vaccine should be administered as two doses, given eight to 12 weeks apart.
The WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) added, however, that countries should be able to administer the two doses over six weeks to ensure more high-priority ... SAGE made a provision for countries in exceptional
Biogen has bet up to $3.1bn on a series of potential depression and movement disorder therapies currently being developed by Sage Therapeutics. ... In the US, Biogen and Sage will share responsibility and costs for development, as well as profits and
According to the government’s Scientific Advisory Group (SAGE), 80% of the contacts of people with the virus need to self-isolate to prevent the infection rate rising.
More from news
Approximately 8 fully matching, plus 16 partially matching documents found.
Interim guidance published by the WHO Strategic Advisory Group of Experts (SAGE) on 21 September suggests that there is a need to reconsider the prioritisation of risk groups for influenza vaccination
Globally, we've seen a deal struck between US firms Abbott and Alere for $5.8bn, while on the same day Stryker agreed to buy Sage for around $2.8bn.
Turning to medtech, Stryker has had a busy month acquiring two companies, Sage Products and Physio-Control, paying over $4bn in cash for the two transactions. ... acquisition - company. 5, 800. Sage Products/ Stryker Corporation. portfolio of disposable
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Smoller joined Horizon as chief business officer as part of the form's acquisition of Sage Labs for $48m in September this year. ... company.”. His previous roles include the position of CEO at Sage Labs, chief scientific officer of Sigma-Aldrich and
Dr Alves joins from Sage Clinical Development where he served as president and principal consultant.
During her time as director of del Galdo Consulting, del Galdo worked with GSK &Ogilvy Common Health, Freesat, Thomson Reuters, Human Factors International, HomeAway, Sage, and Further on a variety of
CNS appoints CEO alongside new CMO and CFO. Sage Therapeutics has made several changes at the top level, including the appointment of Shire's Dr Jeffrey Jonas as CEO. ... The changes come two years after the formation of the central nervous system (CNS)
More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...